Results for tag: "Xiaflex"

Xiaflex is a biologic drug used to treat musculoskeletal disorders, such as Dupuytren's contracture and Peyronie's disease. It is a recombinant form of collagenase, a naturally occurring enzyme that breaks down collagen, a protein found in the body's connective tissues. Xiaflex is injected directly into the affected area, where it breaks down the collagen and helps to restore normal movement. It is the only FDA-approved treatment for Dupuytren's contracture and Peyronie's disease. Xiaflex is a relatively new drug, having been approved by the FDA in 2010. It has been well-received by the medical community, with many doctors recommending it as a safe and effective treatment for musculoskeletal disorders. The Xiaflex market is composed of a number of companies, including Auxilium Pharmaceuticals, Endo Pharmaceuticals, and Pfizer. These companies are responsible for the production, distribution, and marketing of Xiaflex. They are also involved in research and development of new treatments for musculoskeletal disorders. Show Less Read more